Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-02 Sale |
2025-04-04 7:27 pm |
Monopar Therapeutics | MNPR | Tactic Pharma LLC Robinson Chandler Brown Michael J O'Halloran Thomas V. Mazar Andrew Paul 10% Owner |
33,334 | $35 | $1,166,690 | 822,255 (Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 7:35 pm |
Monopar Therapeutics | MNPR | Tactic Pharma LLC Mazar Andrew Paul Robinson Chandler O'Halloran Thomas V. Brown Michael J 10% Owner |
125,000 | $14.64 | $1,830,620 | 4,277,940 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Exercise |
2025-04-02 9:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
4,106 | $0 | 1,016,251 (Direct) |
View |
| 2025-03-31 Tax Withholding |
2025-04-02 9:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
1,204 | $36.41 | 1,016,251 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-07 9:24 pm |
N/A 2035-03-04 |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
165,658 | $0 | 1,207,991 (Direct) |
View |
| 2025-03-04 Exercise |
2025-03-07 9:24 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
6,002 | $0 | 1,207,991 (Direct) |
View |
| 2025-03-04 Tax Withholding |
2025-03-07 9:24 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
1,759 | $31.7 | 1,207,991 (Direct) |
View |
| 2024-12-31 Tax Withholding |
2025-01-02 6:14 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
2,209 | $22 | 939,316 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-02 6:14 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
4,895 | $0 | 939,316 (Direct) |
View |
| 2024-09-30 Tax Withholding |
2024-10-02 7:45 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
1,918 | $6.74 | 941,525 (Direct) |
View |
| 2024-09-30 Exercise |
2024-10-02 7:45 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
4,895 | $0 | 941,525 (Direct) |
View |
| 2024-06-30 Tax Withholding |
2024-07-02 6:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
8,684 | $0.731 | 4,717,198 (Direct) |
View |
| 2024-06-30 Exercise |
2024-07-02 6:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
24,476 | $0 | 4,717,198 (Direct) |
View |
| 2024-05-28 Exercise |
2024-05-30 6:10 pm |
N/A 2026-04-03 |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
84,000 | $0 | 4,528,071 (Direct) |
View |
| 2024-05-28 Exercise |
2024-05-30 6:10 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
84,000 | $0.001 | 4,528,071 (Direct) |
View |
| 2024-03-31 Exercise |
2024-04-02 8:33 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
24,474 | $0 | 4,641,882 (Direct) |
View |
| 2024-03-31 Tax Withholding |
2024-04-02 8:33 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
7,172 | $0.681 | 4,641,882 (Direct) |
View |
| 2023-12-31 Exercise |
2024-01-03 7:36 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
31,198 | $0 | 9,156,003 (Direct) |
View |
| 2023-12-31 Tax Withholding |
2024-01-03 7:36 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
10,796 | $0.3402 | 9,156,003 (Direct) |
View |
| 2023-09-30 Exercise |
2023-10-03 7:37 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
24,474 | $0 | 4,659,850 (Direct) |
View |
| 2023-09-30 Tax Withholding |
2023-10-03 7:37 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
7,172 | $0.6199 | 4,659,850 (Direct) |
View |
| 2023-06-30 Tax Withholding |
2023-07-03 6:45 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
10,269 | $0.855 | 4,667,022 (Direct) |
View |
| 2023-06-30 Exercise |
2023-07-03 6:45 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
35,039 | $0 | 4,667,022 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 5:17 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
13,911 | $0 | 4,677,291 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 5:17 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
4,286 | $1.39 | 4,677,291 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 6:49 pm |
N/A 2033-02-01 |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
390,851 | $0 | 548,746 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-03 3:59 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
7,141 | $2.37 | 8,790,505 (Direct) |
View |
| 2022-12-31 Exercise |
2023-01-03 3:59 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
20,635 | $0 | 8,790,505 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2022-10-03 7:55 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
4,077 | $1.52 | 4,519,706 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-03 7:55 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
13,911 | $0 | 4,519,706 (Direct) |
View |
| 2022-06-30 Exercise |
2022-07-01 4:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
23,882 | $0 | 4,523,783 (Direct) |
View |
| 2022-06-30 Tax Withholding |
2022-07-01 4:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
6,999 | $2.299 | 4,523,783 (Direct) |
View |
| 2022-03-31 Tax Withholding |
2022-04-01 5:28 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
1,155 | $2.55 | 4,530,782 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-01 5:28 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
3,941 | $0 | 4,530,782 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 7:37 pm |
N/A 2032-02-01 |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
370,540 | $0 | 431,282 (Direct) |
View |
| 2022-01-01 Exercise |
2022-01-04 2:17 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
6,724 | $0 | 4,325,120 (Direct) |
View |
| 2022-01-01 Tax Withholding |
2022-01-04 2:17 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
2,327 | $3.21 | 4,325,120 (Direct) |
View |
| 2021-12-31 Exercise |
2022-01-04 2:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
3,941 | $0 | 4,354,571 (Direct) |
View |
| 2021-12-31 Tax Withholding |
2022-01-04 2:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
1,364 | $3.21 | 4,354,571 (Direct) |
View |
| 2021-09-30 Exercise |
2021-10-01 7:24 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
3,941 | $0 | 4,355,935 (Direct) |
View |
| 2021-09-30 Tax Withholding |
2021-10-01 7:24 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
1,155 | $4.87 | 4,355,935 (Direct) |
View |
| 2021-06-30 Tax Withholding |
2021-07-02 5:10 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
2,310 | $5.89 | 4,357,090 (Direct) |
View |
| 2021-06-30 Exercise |
2021-07-02 5:10 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
7,883 | $0 | 4,357,090 (Direct) |
View |
| 2021-01-26 Option Award |
2021-01-28 6:51 pm |
N/A 2031-01-25 |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
133,060 | $0 | 153,231 (Direct) |
View |
| 2021-01-01 Exercise |
2021-01-05 5:40 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
6,724 | $0 | 4,441,511 (Direct) |
View |
| 2021-01-01 Tax Withholding |
2021-01-05 5:40 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
2,327 | $6.12 | 4,441,511 (Direct) |
View |